A Science study found that recurrent mutations in the promoter of the telomerase gene, TERT, could be responsible for overexpression of telomerase in a majority of cancers, thereby sustaining the ...
A research team in Japan has developed an innovative system that can accurately detect genetic mutations in the brain tumor within just 25 minutes. Genetic mutations are crucial markers for diagnosis ...
This initiative was led by Alexander C. Mackinnon, M.D., Ph.D., Robert B. Adams Endowed Professor, Executive Vice Chair, Division Director, Genomic Diagnostics and ...
A research team in Japan has developed an innovative system that can accurately detect genetic mutations in the brain tumor within just 25 minutes. Genetic mutations are crucial markers for diagnosis ...
Researchers in the RIKEN Center for Brain Science (CBS) examined the genetics of autism spectrum disorder (ASD) by analyzing mutations in the genomes of individuals and their families. They discovered ...
Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers. Phase III LEAP-010 study: first-line pembrolizumab with or without lenvatinib in recurrent/metastatic (R/M) ...
Around 98.5% of human DNA is non-coding, meaning it doesn’t get copied to make proteins. A new study has connected many of these non-coding regions to the genes they affect and laid out guidelines for ...
A research team co-led by scientists at the Netherlands Cancer Institute (NKI) and Oncode Institute has developed a deep learning model, PARM (promoter activity regulatory model) that offers up new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results